Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
Pharma News, Views & Analysis
Filter
News
Articles
Podcasts
Infographics
Advertise With Us
Advertise With Us
AstraZeneca’s NSCLC drug approved by European Commission
The European Commission has approved a new regimen from AstraZeneca, which combines the company’s durvalumab with chemotherapy for patients with resectable NSCLC
Read more
AstraZeneca’s NSCLC drug approved by European Commission
The European Commission has approved a new regimen from AstraZeneca, which combines the company’s durvalumab with chemotherapy for patients with resectable NSCLC
Novo Nordisk announces significant leadership reshuffle
Novo Nordisk has announced major leadership changes, with EVP Camilla Sylvest departing and Ludovic Helfgott taking on an expanded role.
Spotlight: March 2025
From the latest news impacting the UK’s NHS to large industry acquisitions, March brought a range of impactful news.
Spoonful of technology: Jan-March 2025
Discover the latest pharma innovations, from needle-free vaccines to NHS data access and interactive case studies in medical education.
Could gene therapy transform heart failure treatment?
A gene therapy for heart failure with preserved ejection fraction (HFpEF) has shown promising early results.
Sanofi's chlamydia vaccine fast-tracked by FDA
This decision underscores the need for a preventative measure against the chlamydia, which affects millions worldwide.
New study shines light on dementia in the workplace
A new study is challenging the belief that dementia is incompatible with modern work environments, with AI helping employees stay in work.
Pharma’s innovation ROI: Gains made, challenges ahead
The biopharmaceutical industry’s return on investment in innovation is increasing, but R&D costs are rising, according to a new Deloitte report.
Loading posts...
1
2
3
…
25
Next »